227 related articles for article (PubMed ID: 38622003)
1. Orexinergic Receptor Antagonists as a New Therapeutic Target to Overcome Limitations of Current Pharmacological Treatment of Insomnia Disorder.
Álamo C; Sáiz Ruiz J; Zaragozá Arnáez C
Actas Esp Psiquiatr; 2024 Apr; 52(2):172-182. PubMed ID: 38622003
[TBL] [Abstract][Full Text] [Related]
2. Insomnia in Elderly Patients: Recommendations for Pharmacological Management.
Abad VC; Guilleminault C
Drugs Aging; 2018 Sep; 35(9):791-817. PubMed ID: 30058034
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia Disorder.
Kunz D; Dauvilliers Y; Benes H; García-Borreguero D; Plazzi G; Seboek Kinter D; Coloma P; Rausch M; Sassi-Sayadi M; Thein S
CNS Drugs; 2023 Jan; 37(1):93-106. PubMed ID: 36484969
[TBL] [Abstract][Full Text] [Related]
4. Daridorexant for the treatment of insomnia disorder: findings and implications.
Dos Santos JBR; da Silva MRR
Eur J Clin Pharmacol; 2022 Nov; 78(11):1749-1761. PubMed ID: 36098753
[TBL] [Abstract][Full Text] [Related]
5. Insomnia Management: A Review and Update.
Shaha DP
J Fam Pract; 2023 Jul; 72(6 Suppl):S31-S36. PubMed ID: 37549414
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic Treatment of Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians.
Wilt TJ; MacDonald R; Brasure M; Olson CM; Carlyle M; Fuchs E; Khawaja IS; Diem S; Koffel E; Ouellette J; Butler M; Kane RL
Ann Intern Med; 2016 Jul; 165(2):103-12. PubMed ID: 27136278
[TBL] [Abstract][Full Text] [Related]
7. Emerging and upcoming therapies in insomnia.
Kim WJ; Kim HS
Transl Clin Pharmacol; 2024 Mar; 32(1):1-17. PubMed ID: 38586124
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis.
De Crescenzo F; D'Alò GL; Ostinelli EG; Ciabattini M; Di Franco V; Watanabe N; Kurtulmus A; Tomlinson A; Mitrova Z; Foti F; Del Giovane C; Quested DJ; Cowen PJ; Barbui C; Amato L; Efthimiou O; Cipriani A
Lancet; 2022 Jul; 400(10347):170-184. PubMed ID: 35843245
[TBL] [Abstract][Full Text] [Related]
9. Daridorexant in Insomnia Disorder: A Profile of Its Use.
Nie T; Blair HA
CNS Drugs; 2023 Mar; 37(3):267-274. PubMed ID: 36754930
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders.
Muehlan C; Vaillant C; Zenklusen I; Kraehenbuehl S; Dingemanse J
Expert Opin Drug Metab Toxicol; 2020 Nov; 16(11):1063-1078. PubMed ID: 32901578
[TBL] [Abstract][Full Text] [Related]
11. Review of Safety and Efficacy of Sleep Medicines in Older Adults.
Schroeck JL; Ford J; Conway EL; Kurtzhalts KE; Gee ME; Vollmer KA; Mergenhagen KA
Clin Ther; 2016 Nov; 38(11):2340-2372. PubMed ID: 27751669
[TBL] [Abstract][Full Text] [Related]
12. Clinical safety and narcolepsy-like symptoms of dual orexin receptor antagonists in patients with insomnia: a systematic review and meta-analysis.
Na HJ; Jeon N; Staatz CE; Han N; Baek IH
Sleep; 2024 Feb; 47(2):. PubMed ID: 37950346
[TBL] [Abstract][Full Text] [Related]
13. Daridorexant for the Treatment of Insomnia.
Robinson CL; Supra R; Downs E; Kataria S; Parker K; Kaye A; Viswanath O; Urits I
Health Psychol Res; 2022; 10(3):37400. PubMed ID: 36045942
[TBL] [Abstract][Full Text] [Related]
14. The orexin story and orexin receptor antagonists for the treatment of insomnia.
Muehlan C; Roch C; Vaillant C; Dingemanse J
J Sleep Res; 2023 Dec; 32(6):e13902. PubMed ID: 37086045
[TBL] [Abstract][Full Text] [Related]
15. Discovery and development of orexin receptor antagonists as therapeutics for insomnia.
Winrow CJ; Renger JJ
Br J Pharmacol; 2014 Jan; 171(2):283-93. PubMed ID: 23731216
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Daridorexant in Older and Younger Adults with Insomnia Disorder: A Secondary Analysis of a Randomised Placebo-Controlled Trial.
Fietze I; Bassetti CLA; Mayleben DW; Pain S; Seboek Kinter D; McCall WV
Drugs Aging; 2022 Oct; 39(10):795-810. PubMed ID: 36098936
[TBL] [Abstract][Full Text] [Related]
17. Review of the Efficacy and Safety of Lemborexant, a Dual Receptor Orexin Antagonist (DORA), in the Treatment of Adults With Insomnia Disorder.
Waters K
Ann Pharmacother; 2022 Feb; 56(2):213-221. PubMed ID: 34078141
[TBL] [Abstract][Full Text] [Related]
18. The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023.
Riemann D; Espie CA; Altena E; Arnardottir ES; Baglioni C; Bassetti CLA; Bastien C; Berzina N; Bjorvatn B; Dikeos D; Dolenc Groselj L; Ellis JG; Garcia-Borreguero D; Geoffroy PA; Gjerstad M; Gonçalves M; Hertenstein E; Hoedlmoser K; Hion T; Holzinger B; Janku K; Jansson-Fröjmark M; Järnefelt H; Jernelöv S; Jennum PJ; Khachatryan S; Krone L; Kyle SD; Lancee J; Leger D; Lupusor A; Marques DR; Nissen C; Palagini L; Paunio T; Perogamvros L; Pevernagie D; Schabus M; Shochat T; Szentkiralyi A; Van Someren E; van Straten A; Wichniak A; Verbraecken J; Spiegelhalder K
J Sleep Res; 2023 Dec; 32(6):e14035. PubMed ID: 38016484
[TBL] [Abstract][Full Text] [Related]
19. The Comparative Effectiveness and Safety of Insomnia Drugs: A Systematic Review and Network Meta-Analysis of 153 Randomized Trials.
Pan B; Ge L; Lai H; Hou L; Tian C; Wang Q; Yang K; Lu Y; Zhu H; Li M; Wang D; Li X; Zhang Y; Gao Y; Liu M; Ding G; Tian J; Yang K
Drugs; 2023 May; 83(7):587-619. PubMed ID: 36947394
[TBL] [Abstract][Full Text] [Related]
20. Antidepressants for insomnia in adults.
Everitt H; Baldwin DS; Stuart B; Lipinska G; Mayers A; Malizia AL; Manson CC; Wilson S
Cochrane Database Syst Rev; 2018 May; 5(5):CD010753. PubMed ID: 29761479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
